Why is Astec Lifescienc falling/rising?

As of 01-Jul, Astec Lifesciences Ltd is experiencing a price increase, currently at Rs 969.00, reflecting a change of 41.05 (4.42%) upward. The stock has shown a notable performance today, having outperformed its sector by 3.37% and marking a trend reversal after two consecutive days of decline. It reached an intraday high of Rs 976, indicating strong intraday momentum. However, despite this positive movement, the stock has a concerning long-term outlook, with a -212.13% CAGR growth in operating profits over the last five years and negative results reported for the last four consecutive quarters, including a significant drop in net sales and profit after tax.
In the broader market context, Astec Lifesciences has outperformed the Sensex in the short term, with a 17.80% return over the past week compared to the Sensex's 2.00%. However, the stock's year-to-date performance remains negative at -3.58%, contrasting with the Sensex's positive return of 7.11%. The recent increase in promoter confidence, with a 4.12% increase in their stake, suggests a belief in the company's future potential, yet the stock's long-term fundamental weaknesses and consistent underperformance against benchmarks over the last three years raise concerns about its sustainability.